|
1
|
Carbone M, Ly BH, Dodson RF, Pagano I,
Morris PT, Dogan UA, Gazdar AF, Pass HI and Yang H: Malignant
mesothelioma: Facts, myths, and hypotheses. J Cell Physiol.
227:44–58. 2012. View Article : Google Scholar
|
|
2
|
Pass HI, Vogelzang N, Hahn S and Carbone
M: Malignant pleural mesothelioma. Curr Probl Cancer. 28:93–174.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Attanoos RL and Gibbs AR: Pathology of
malignant mesothelioma. Histopathology. 30:403–418. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Linton A, Cheng YY, Griggs K, Kirschner
MB, Gattani S, Srikaran S, Chuan-Hao Kao S, McCaughan BC, Klebe S,
van Zandwijk N, et al: An RNAi-based screen reveals PLK1, CDK1 and
NDC80 as potential therapeutic targets in malignant pleural
mesothelioma. Br J Cancer. 110:510–519. 2014. View Article : Google Scholar :
|
|
5
|
Spugnini EP, Bosari S, Citro G, Lorenzon
I, Cognetti F and Baldi A: Human malignant mesothelioma: Molecular
mechanisms of pathogenesis and progression. Int J Biochem Cell
Biol. 38:2000–2004. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tatsuta T, Hosono M, Takahashi K, Omoto T,
Kariya Y, Sugawara S, Hakomori S and Nitta K: Sialic acid-binding
lectin (leczyme) induces apoptosis to malignant mesothelioma and
exerts synergistic antitumor effects with TRAIL. Int J Oncol.
44:377–384. 2014.
|
|
7
|
Sahin AA, Cöplü L, Selçuk ZT, Eryilmaz M,
Emri S, Akhan O and Bariş YI: Malignant pleural mesothelioma caused
by environmental exposure to asbestos or erionite in rural Turkey:
CT findings in 84 patients. AJR Am J Roentgenol. 161:533–537. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carbone M, Kratzke RA and Testa JR: The
pathogenesis of mesothelioma. Semin Oncol. 29:2–17. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zucali PA, Ceresoli GL, De Vincenzo F,
Simonelli M, Lorenzi E, Gianoncelli L and Santoro A: Advances in
the biology of malignant pleural mesothelioma. Cancer Treat Rev.
37:543–558. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cedrés S, Montero MA, Zamora E, Martínez
A, Martínez P, Fariñas L, Navarro A, Torrejon D, Gabaldon A, Ramon
Y, Cajal S, et al: Expression of Wilms' tumor gene (WT1) is
associated with survival in malignant pleural mesothelioma. Clin
Transl Oncol. 16:776–782. 2014. View Article : Google Scholar
|
|
11
|
Martinis UJ and Radovic VR: Pleural
mesothelioma in patient with pulmonary tuberculosis: Report of a
case. Dis Chest. 47:568–570. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tanaka I, Osada H, Fujii M, Fukatsu A,
Hida T, Horio Y, Kondo Y, Sato A, Hasegawa Y, Tsujimura T, et al:
LIM-domain protein AJUBA suppresses malignant mesothelioma cell
proliferation via Hippo signaling cascade. Oncogene. 34:73–83.
2015. View Article : Google Scholar
|
|
13
|
Safe S and Abdelrahim M: Sp transcription
factor family and its role in cancer. Eur J Cancer. 41:2438–2448.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aslam F, Palumbo L, Augenlicht LH and
Velcich A: The Sp family of transcription factors in the regulation
of the human and mouse MUC2 gene promoters. Cancer Res. 61:570–576.
2001.PubMed/NCBI
|
|
15
|
Black AR, Black JD and Azizkhan-Clifford
J: Sp1 and krüppel-like factor family of transcription factors in
cell growth regulation and cancer. J Cell Physiol. 188:143–160.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsuda M, Okamoto K, Muguruma N, Sannomiya
K, Nakagawa T, Miyamoto H, Kitamura S, Goji T, Kimura T, Okahisa T,
et al: Suppressive effect of RAS inhibitor manumycin A on aberrant
crypt foci formation in the azoxymethane-induced rat colorectal
carcinogenesis model. J Gastroenterol Hepatol. 28:1616–1623.
2013.PubMed/NCBI
|
|
17
|
Hara M, Akasaka K, Akinaga S, Okabe M,
Nakano H, Gomez R, Wood D, Uh M and Tamanoi F: Identification of
Ras farnesyltransferase inhibitors by microbial screening. Proc
Natl Acad Sci USA. 90:2281–2285. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singha PK, Pandeswara S, Venkatachalam MA
and Saikumar P: Manumycin A inhibits triple-negative breast cancer
growth through LC3-mediated cytoplasmic vacuolation death. Cell
Death Dis. 4:e4572013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kainuma O, Asano T, Hasegawa M, Kenmochi
T, Nakagohri T, Tokoro Y and Isono K: Inhibition of growth and
invasive activity of human pancreatic cancer cells by a
farnesyltransferase inhibitor, manumycin. Pancreas. 15:379–383.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yeung SC, Xu G, Pan J, Christgen M and
Bamiagis A: Manumycin enhances the cytotoxic effect of paclitaxel
on anaplastic thyroid carcinoma cells. Cancer Res. 60:650–656.
2000.PubMed/NCBI
|
|
21
|
Pan J, Xu G and Yeung SC: Cytochrome c
release is upstream to activation of caspase-9, caspase-8, and
caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer
cells induced by manumycin and paclitaxel. J Clin Endocrinol Metab.
86:4731–4740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Di Paolo A, Danesi R, Nardini D, Bocci G,
Innocenti F, Fogli S, Barachini S, Marchetti A, Bevilacqua G and
Del Tacca M: Manumycin inhibits ras signal transduction pathway and
induces apoptosis in COLO320-DM human colon tumour cells. Br J
Cancer. 82:905–912. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou JM, Zhu XF, Pan QC, Liao DF, Li ZM
and Liu ZC: Manumycin induces apoptosis in human hepatocellular
carcinoma HepG2 cells. Int J Mol Med. 12:955–959. 2003.PubMed/NCBI
|
|
24
|
Wang W and Macaulay RJ: Apoptosis of
medulloblastoma cells in vitro follows inhibition of farnesylation
using manumycin A. Int J Cancer. 82:430–434. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Selleri C, Maciejewski JP, Montuori N,
Ricci P, Visconte V, Serio B, Luciano L and Rotoli B: Involvement
of nitric oxide in farnesyltransferase inhibitor-mediated apoptosis
in chronic myeloid leukemia cells. Blood. 102:1490–1498. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
She M, Pan I, Sun L and Yeung SC:
Enhancement of manumycin A-induced apoptosis by methoxyamine in
myeloid leukemia cells. Leukemia. 19:595–602. 2005.PubMed/NCBI
|
|
27
|
Frassanito MA, Cusmai A, Piccoli C and
Dammacco F: Manumycin inhibits farnesyltransferase and induces
apoptosis of drug-resistant interleukin 6-producing myeloma cells.
Br J Haematol. 118:157–165. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sears KT, Daino H and Carey GB: Reactive
oxygen species-dependent destruction of MEK and Akt in Manumycin
stimulated death of lymphoid tumor and myeloma cell lines. Int J
Cancer. 122:1496–1505. 2008. View Article : Google Scholar
|
|
29
|
Pathak S, Sharma C, Jayaram HN and Singh
N: Apoptotic signaling induced by benzamide riboside: An in vitro
study. Mol Cell Biochem. 328:67–73. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Reed JC: Apoptosis mechanisms:
Implications for cancer drug discovery. Oncology (Williston Park).
18(Suppl 10): 11–20. 2004.
|
|
31
|
Lowe SW and Lin AW: Apoptosis in cancer.
Carcinogenesis. 21:485–495. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Courey AJ and Tjian R: Analysis of Sp1 in
vivo reveals multiple transcriptional domains, including a novel
glutamine-rich activation motif. Cell. 55:887–898. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cho JJ, Chae JI, Yoon G, Kim KH, Cho JH,
Cho SS, Cho YS and Shim JH: Licochalcone A, a natural chalconoid
isolated from Glycyrrhiza inflata root, induces apoptosis via Sp1
and Sp1 regulatory proteins in oral squamous cell carcinoma. Int J
Oncol. 45:667–674. 2014.PubMed/NCBI
|
|
34
|
Banjerdpongchai R, Wudtiwai B and Pompimon
W: Stigmalactam from Orophea enterocarpa induces human cancer cell
apoptosis via a mitochondrial pathway. Asian Pac J Cancer Prev.
15:10397–10400. 2014. View Article : Google Scholar
|
|
35
|
Lim SW, Loh HS, Ting KN, Bradshaw TD and
Zeenathul NA: Antiproliferation and induction of
caspase-8-dependent mitochondria-mediated apoptosis by
β-tocotrienol in human lung and brain cancer cell lines. Biomed
Pharmacother. 68:1105–1115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang X, Du T, Wang X, Zhang Y, Hu W, Du X,
Miao L and Han C: IDH1, a CHOP and C/EBPβ-responsive gene under ER
stress, sensitizes human melanoma cells to hypoxia-induced
apoptosis. Cancer Lett. 365:201–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ghosh AP, Klocke BJ, Ballestas ME and Roth
KA: CHOP potentially co-operates with FOXO3a in neuronal cells to
regulate PUMA and BIM expression in response to ER stress. PLoS
One. 7:e395862012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kharbanda S, Pandey P, Schofield L,
Israels S, Roncinske R, Yoshida K, Bharti A, Yuan ZM, Saxena S,
Weichselbaum R, et al: Role for Bcl-xL as an inhibitor of cytosolic
cytochrome C accumulation in DNA damage-induced apoptosis. Proc
Natl Acad Sci USA. 94:6939–6942. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wong WW and Puthalakath H: Bcl-2 family
proteins: The sentinels of the mitochondrial apoptosis pathway.
IUBMB Life. 60:390–397. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Scatena R: Mitochondria and cancer: A
growing role in apoptosis, cancer cell metabolism and
dedifferentiation. Adv Exp Med Biol. 942:287–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
